tbuckley/cabot-search huggingface dataset:
Advocates say smoke-free society eventually may result from more curbs, taxes on tobacco use
Authors: C. Marwick
Journal: JAMA (1993)

MOST CHAMPIONS of a smoke-free society agree that among their top priorities this year are the following: To discourage youngsters from starting to smoke. To increase excise taxes on cigarettes by $2 a pack, with similar increases for other tobacco products. To extend existing ordinances requiring smoke-free public places. To curb advertising and promotion of tobacco products. But implementing these goals is likely to be uphill work, warns Michael Pertschuk, codirector, Advocacy Institute, Washington, DC, a group that helps to plan and coordinate tobacco-control advocacy. The antismoking movement, he says, is not well placed to combat the powerful tobacco industry lobby. <h3>More Focus Needed?</h3> "The limited financial resources committed by both government and nongovernment funders are, too often, misdirected," Pertschuk says. "We still lack the structures and capacity for overall priority setting, strategic planning, tactical coordination, and effective communications." In his opinion, Pertschuk says, aside from objectives laid out by
Die Kollapstherapie der Lungentuberkulose mit besonderer Berücksichtigung des künstlichen Pneumothorax.
Journal: JAMA (1928)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Papillary Stenosis
Authors: M Guelrud
Journal: Endoscopy (1988)

The present state of papillary stenosis is reviewed. ERCP manometry has become the most important means of evaluating sphincter of Oddi dynamics. Pressure measurements in the sphincter segment appear useful to differentiate patients with sphincter of Oddi dysfunction from patients with an organic stenosis. The author's experience with sphincter of Oddi manometry, with endoscopic sphincterotomy and hydrostatic balloon dilation of the sphincter of Oddi, and the results of an international inquiry, are presented.
Economic barriers to the use of oral rehydration therapy. A case report
Authors: A. Meyers
Journal: JAMA (1991)

Diarrheal dehydration is a highly prevalent condition among young children and is readily prevented and treated with oral rehydration therapy. We report a death due to hypernatremic dehydration caused by rotavirus diarrhea of a 9-month-old infant whose mother attempted to purchase oral glucose-electrolyte solution in a pharmacy but was unable to afford it. While efforts such as the National ORT Project should help to promote the proper at-home treatment of this condition, we conclude that oral rehydration therapy will not be used optimally by the parents of children living in poverty until the economic barriers to its use are removed. (<i>JAMA</i>. 1991;265:1724-1725)
Frozen Shoulder
Authors: Paulette Roeske
Journal: JAMA (2000)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Abstract 97: Resistance Values in the Limbs are Useful for Estimating the Severity of Kawasaki Disease.
Authors: Yuichi Nomura, Kiminori Masuda, Yasuko Morita, Yumiko Ninomiya, Kentaro Ueno, Taisuke Eguchi, Yoshifumi Kawano
Journal: Circulation (2015)

Vascular permeability is one of the characteristics of vasculitis in Kawasaki disease (KD) and is closely related to indurative edema. Evaluating indurative edema may be useful for estimating the severity of KD. Indurative edema is correlated with resistance values in the limbs. Therefore, we evaluated the efficacy of resistance values in the limbs in KD patients, as measured by a multiple-frequency bioelectrical-impedance method, for estimating the severity of KD. Patients and Methods: In 38 patients with the acute phase of KD (before intravenous immunoglobulin treatment; IVIG), 32 with the sub-acute phase (after IVIG), and 49 controls, we measured resistance (impedance; IMP) in each child’s total body, forearm, and lower leg at frequencies of 0 and infinity (IMP-0 and IMP-∞, respectively) using MLT-550N (Sekisui ). Corrected Imp values (coIMP; Imp x limb’s cross-sectional area/ limb’s length) were also examined. Results: IMP values were not different among patients with the acute and sub-acute phases of KD and controls. However, coIMP values in the forearm of patients in the acute phase of KD were significantly higher than those of controls (coIMP-0 Ωcm: 197±50 vs. 164±35, P&lt;0.001, coIMP-∞; 151±42 vs. 125±36, P=0.003). These values were decreased to 181±46 Ωcm for coIMP-0 and 144±44 Ωcm for coIMP-∞ at the sub-acute phase and were still significantly higher than those of controls. Values of coIMP in the lower leg showed similar changes to those in the forearm. The values of coIMP in the forearm of IVIG non-responders at the acute phase were higher than those of responders, but this difference was not significant. Conclusion: Values of co-IMP in the forearm might be useful for estimating the severity of KD.
Fall in coronary deaths in Poland may be linked to lower meat and butter intake
Journal: BMJ (1998)

Women who smoke have a greater risk of myocardial infarction than men who smoke Studies of smoking and cardiovascular disease may have underestimated the risk in women because until recently women's smoking habits have differed greatly from men's.During the past few decades, however, women have taken up smoking like men.Using data from three large prospective studies in Copenhagen that included many women who were heavy smokers, Prescott et al (p 1043) found that the smoking related risk of myocardial infarction was 50% higher in women than in men.This difference may be caused by interactions between components of tobacco smoke and hormonal factors.
Books Received
Journal: JAMA (1982)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Articular oxalate crystals and the taxonomy of gout
Authors: P. A. Simkin
Journal: JAMA (1988)

In this issue ofTHE JOURNAL, Rosenthal et al<sup>1</sup>report the case of an anephric, dialyzed patient experiencing acute arthritis associated with calcium oxalate crystals. Together with reports from Hoffman et al,<sup>2</sup>Schumacher et al,<sup>3</sup>and Reginato et al,<sup>4</sup>this observation establishes an unequivocal place for oxalate among the solutes that abnormally crystallize in and around human joints. As yet, these authors, who together with Paul Dieppe are the leading students of crystalinduced disease, have not settled on a simple name for this
Male-to-female transmission of HIV
Journal: JAMA (1987)

<h3>To the Editor.—</h3> I was concerned about the nonchalant and confusing discussion of some troubling findings in the study of Padian et al.<sup>1</sup> Although absolutely no data are presented, several statements are made regarding condom use and a lack of evident protection from infection with human immunodeficiency virus (HIV). A statement in the abstract, indicating that condom use was not associated with infection, seems to contradict a statement later in the article indicating that "condom use was not significantly associated with protection from infection." Confusingly, a later statement indicates that "failure to use condoms was not significantly associated with infection." The findings hinted at in the statements are extremely troubling, since the use of condoms is being championed as the primary means of achieving "safe sex" in our sexually liberated society. Since no data are presented, it is difficult to draw one's own conclusions. However, the clear implication from
Keyword Index Volumes 65+66
Journal: Cardiovascular Research (2005)

Keyword Index -Volumes 65 + 66 ABCA-1 (66) 141 Acetylsalicylic acid (66) 141 Acidosis (66) 55 Action potential prolongation (65) 397 Adenosine (65) 803, (66) 245 Adenosine receptors (66) 245 Adenovirus (65) 177 Adenylyl cyclase (66) 503 Adipose tissue (65) 328 Adrenergic agonist (65) 187 Adrenergic agonists (65) 230 Adrenergic (ant)agonists (65) 28 h-Adrenoceptor (66) 512 Adrenoceptors (66) 256 Adrenomedullin (66) 104 Adventitia (65) 478 Aging (66) 194, (66) 205, (66) 213, (66) 222, (66) 233, (66) 245, (66) 295, (66) 307, (66) 318, (66) 353, (66) 364, (66) 374, (66) 393 Allograft vasculopathy (65) 283 All-trans retinoic acid (65) 743 Alpha 1 adrenergic receptors (65) 436 Angiogenesis (65) 64, (65) 513, (65) 550, (65) 574, (65) 587, (65) 599, (65) 639, (65) 649, (65) 656, (65) 728, (66) 45, (66) 543 Angiotensin (65) 73 Angiotensin II (65) 374, (65) 478, (66) 503 Animal model (65) 469 Annexin (65) 793 Antherogenesis (65) 587 Antibiotics (65) 317 Aortic allograft (65) 283 AP-1 (65) 719 Apelin (65) 73, (65) 743 APJ (65) 73, (65) 743 Apoptosis (65) 535, (66) 179, (66) 543 h-Arrestins (66) 512 Arrhythmia (65) 128, (66) 64 Arrhythmia (mechanisms) (65) 104, (65) 138, (66) 353 Arterial thrombosis (65) 907 Arterial-venous differentiation (65) 619 arteries (66) 162 Arteries (65) 387, (65) 711, (65) 813, (65) 913, (66) 307 Arteriogenesis (65) 619, (65) 574, (65) 649 ASIC3 (65) 405 Aspirin (66) 141 AT 2 receptors (65) 478 Atrial function (65) 221 Atherosclerosis (66) 162 Atherosclerosis (65) 272, (65) 317, (65) 524, (65) 574, (65) 609, (65) 665, (66) 179, (66) 213, (66) 286, (66) 433, (66) 574, (66) 583, (66) 601 Atrial natriuretic peptide (66) 94 Autonomic nervous system (65) 889, (65) 930, (66) 345 Baicalein (65) 244 Baroreflex (65) 930 Beta1-adrenoreceptor (66) 530 Bioapatite (66) 324 Biomineralization (66) 324 Blood vessels (65) 629 BMP-4 (66) 482 Bone marrow (65) 334, (66) 482 Bradykinin receptor (65) 405 Ca 2+ -activated Cl À channels (65) 505 Ca (cellular) (65) 28 Ca-channel (65) 28 Ca2 + handling (65) 793 Calcification (66) 307 Calcium (65) 177, (66) 123 Calcium (cellular) (65) 83 Calcium channel blocker (65) 879 Calcium-activated potassium channel (65) 751 Calcium sensitivity (65) 211 Caloric restriction (66) 205 CaMKII (66) 114 Cancer (65) 581 Candesartan (65) 356 Capillaries (65) 656 Carbon monoxide (65) 751 Cardiac allograft vasculopathy (66) 433 Cardiac cell therapy (65) 305 Cardiac contractility (65) 211 Cardiac fibrosis (65) 782 Cardiac hypertrophy (65) 832 Cardiac imaging (65) 195 Cardiac myocyte (66) 482 Cardiac myosin binding protein C (66) 33 Cardiac remodeling (66) 520 Cardiac transplantation (65) 283 Cardiomyocytes (65) 334, (66) 123, (66) 462 Cardiomyopathy (65) 366, (65) 411, (66) 454 Cardiotrophin-1 (65) 782 Cardioprotection (65) 244, (66) 245, (66) 462 Cardiovascular disease (65) 587, (66) 295 Cardiovascular diseases (65) 317 Cardiovascular risk factors (65) 574 Cardiovascular surgery (65) 737 Catalase (65) 254 CD8 + T lymphocytes (65) 283 CD36 (66) 141 Cell culture (65) 813 Cell cycle (66) 433 Cell differentiation (65) 813 Cell signaling (65)
Journal American Dental Association, Chicago
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
SLU7 downregulation potentiates liver damage through hepatic de-differentiation
Authors: María Gárate-Rascón, Miriam Recalde, Maddalen Jimenez, María Elizalde, María Azkona, Marina Bárcena-Varela, Leticia Colyn, Maria U Latasa, Iker Uriarte, Maite G Fernandez-Barrena, Matías A Avila, Maria Arechederra, Carmen Berasain
Journal: Journal of Hepatology (2020)
Cluster of Haemophilus influenzae type b infections in adults
Authors: P. F. Smith
Journal: JAMA (1988)

<i>Haemophilus influenzae</i>type b commonly causes illness in young children, among whom transmission is known to occur. Most adults are believed to be immune to<i>H influenzae</i>type b and outbreaks of disease among adults appear to be uncommon. From July 14 to Aug 12, 1985, a cluster of six cases of acute febrile illness with cultures positive for<i>H influenzae</i>, biotype II (five cases) or untyped<i>H influenzae</i>(one case), occurred among adults in a nursing home and an adjoining hospital. All six case-patients had personal contact with at least one other case-patient. Among the 46 nursing home residents, men were more likely than women to become ill (44% vs 0%). This cluster of disease suggests that elderly adults may be more susceptible to<i>H influenzae</i>infection than is generally recognized and that outbreaks among adults may result from person-to-person transmission. (<i>JAMA</i>1988;260:1446-1449)
Assessment of the Epidemiological Data Relating Lung Cancer to Air Pollution
Authors: Frank E. Speizer
Journal: Environmental Health Perspectives (1983)

The epidemiological data linking air pollution and lung cancer are derived from statistical associations concerning rates of cancer among urban and rural residents, migrant studies and studies of occupational groups exposed to effluents from fossil fuel combinations. Few, if any of these studies, are adequately adjusted for both relatively simple measures of cigarette smoking or the potentially more subtle effects of the duration of smoking. Because urbanization and industrial sources of air pollution correspond chronologically with the major increases in cigarette smoking, it is not likely that the specific attributable risk to each component can be adequately assessed. Interactions between cigarette smoking and specific air pollutants, similar to those seen between cigarette smoking and asbestos and or radiation, may be occurring. Considering the various estimates made over the last 25 years, it is likely that the effect of air pollution on lung cancer is something greater than zero; however, it is unlikely that the estimate exceeds 2% of all lung cancers or 5/100,000 cases in urban males. Thus, the effect on all cancers is likely to be less than 1% of all cases.
The multi-institutional myeloma group clinico-genomic risk stratification system: A blinded validation
Authors: S. A. Tuchman, W. Chng, A. Anguiano, W. T. Barry, F. Zhan, C. Gasparetto, R. Fonseca, J. D. Shaughnessy, A. Potti
Journal: Journal of Clinical Oncology (2009)

8521 Background: Several clinical and molecular prognostic factors (e.g, International Staging System [ISS] stage, plasma cell labeling index, genomic models) exist for multiple myeloma (MM). We hypothesized that exploiting gene signatures representative of oncogenic pathway deregulation (i.e., Ras, Myc, etc.), would improve MM prognostication and also aid with the identification of novel therapeutic targets. Methods: Using a discovery cohort (n=47) of patients with MM and corresponding gene expression data, we built upon current molecular risk-stratification and devised a Bayesian genomic (“metagene”) model for prognosis. We validated that model in an independent patient cohort (n=207). Finally, we incorporated ISS staging and clinical variables to construct a combined Clinico-Genomic Risk Stratification System. We further validated the combined model in a separate cohort (n=72), in a blinded manner. Results: Using gene signatures predictive of oncogenic pathway activation in the discovery cohort, we identified specific patterns (metagenes) of signaling pathway activation with prognostic relevance. In an independent validation cohort, this metagene-based model accurately predicted event free survival (EFS) independently of ISS (multivariate hazard ratio [HR] 3.4 for ISS stage, and 5.4 for the metagene model, p=0.002). Using multivariate risk modeling, we incorporated ISS staging and the metagene model into a Clinico-Genomic System and successfully stratified the validation cohort into three groups (low, intermediate, and high risk) with markedly different EFS (HR 4.2 for intermediate risk and 14.0 for high risk vs. the low risk cohort, p&lt;0.0001). In an additional blinded validation, the Clinico-Genomic System again accurately predicted median overall survival (68.7 [low risk] vs 24.7 [intermediate risk] vs 18.7 months [high risk], p&lt;0.0001); more accurately than either ISS or other reported genomic models. Conclusions: A combined Clinico-Genomic Risk Stratification System, building on patterns of oncogenic pathway activation and ISS staging system, improves upon current prognostic models in MM and identifies novel pathway targets for future therapeutic consideration. No significant financial relationships to disclose.
The Tilton affair
Authors: M. H. Saffron
Journal: JAMA (1976)

The history of the Medical Department of the Continental Army is a chronicle of intrigue, controversy, and sullied reputations. The brief administration of the first Surgeon-General ended inauspiciously with his imprisonment for treason; his successor, John Morgan, was dismissed abruptly by Congress for alleged incompetence; while Morgan's archrival, William Shippen, Jr, who followed him in office, was eventually tried by court-martial for "malpractice and misconduct." Only John Cochran, the fourth Surgeon-General, managed to leave the service with an unblemished record and the admiration of the entire corps. Victims of this generally unhappy state of affairs were the thousands of hospitalized soldiers, many of whom perished, not from British muskets or bayonets but from ignorance or neglect of basic methods of sanitation and isolation, or from the indifference of a callous and penurious Congress. This paper is concerned with the efforts of one highly motivated and articulate individual who did all within
LAW &amp;amp; MEDICINE
Authors: Angela Roddey Holder
Journal: JAMA (1972)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PD2.05 Overall Survival in Pts with EGFRm+ NSCLC Receiving Sequential Afatinib and Osimertinib: Updated Analysis of the GioTag Study
Authors: M.J. Hochmair, A. Morabito, D. Hao, C.-T. Yang, R.A. Soo, J.C.-H. Yang, R. Gucalp, B. Halmos, L. Wang, A. Märten, T. Cufer
Journal: Journal of Thoracic Oncology (2019)